Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system

AimsThe objective of this study is to compare the adverse events (AEs) associated with pralsetinib and selpercatinib.MethodsTo evaluate the imbalance of AEs linked to pralsetinib and selpercatinib in real-world data, the reporting odds ratio (ROR) was utilized to detect potential signals of AEs. Str...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Qiong Jie, Yuanyuan Li, Li Jing, Jinjin Chen, Yang Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-09-01
Subjects:	pralsetinib selpercatinib adverse drug reactions FAERS pharmacovigilance
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1424980/full